# reload+after+2024-01-22 19:31:11.755633
address1§444 West Lake Street
address2§Suite 1700
city§Chicago
state§IL
zip§60606
country§United States
phone§312 416 8592
website§https://www.MAIABiotech.com
industry§Biotechnology
sector§Healthcare
longBusinessSummary§MAIA Biotechnology, Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of therapies targeting cancer. The company's lead product candidate is THIO, a telomere-targeting agent that is in Phase II clinical study to evaluate its activity in patients with non-small cell lung cancer. It is also developing second generation telomere targeting agents. MAIA Biotechnology, Inc. was incorporated in 2018 and is headquartered in Chicago, Illinois.
fullTimeEmployees§18
companyOfficers§[{'maxAge': 1, 'name': 'Dr. Vlad  Vitoc M.B.A., M.D.', 'age': 52, 'title': 'Co-Founder, President, CEO & Chairman of the Board of Directors', 'yearBorn': 1971, 'fiscalYear': 2022, 'totalPay': 715550, 'exercisedValue': 0, 'unexercisedValue': 3248211}, {'maxAge': 1, 'name': 'Dr. Sergei M. Gryaznov Ph.D.', 'age': 63, 'title': 'Chief Scientific Officer', 'yearBorn': 1960, 'fiscalYear': 2022, 'totalPay': 524769, 'exercisedValue': 0, 'unexercisedValue': 1457995}, {'maxAge': 1, 'name': 'Mr. Jeffrey C. Himmelreich', 'title': 'Head of Finance', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Linda  Moreira', 'title': 'Company Secretary', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}]
compensationAsOfEpochDate§1672444800
maxAge§86400
priceHint§4
payoutRatio§0.0
currency§USD
dateShortInterest§1702598400
forwardEps§-1.58
exchange§ASE
quoteType§EQUITY
shortName§MAIA Biotechnology, Inc.
longName§MAIA Biotechnology, Inc.
firstTradeDateEpochUtc§1659015000
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§0f42043f-a188-3808-9a57-e38f76c4260b
gmtOffSetMilliseconds§-18000000
targetHighPrice§14.0
targetLowPrice§14.0
targetMeanPrice§14.0
targetMedianPrice§14.0
recommendationMean§2.0
recommendationKey§buy
numberOfAnalystOpinions§1
quickRatio§1.499
grossMargins§0.0
ebitdaMargins§0.0
trailingPegRatio§None
